Financial Performance - Operating revenue for Q1 2025 was CNY 24,298,661.55, down 29.11% from CNY 34,275,554.02 in the same period last year[11] - Net profit attributable to shareholders was a loss of CNY 887,474.06, representing a decline of 108.72% compared to a profit of CNY 10,180,355.88 in Q1 2024[11] - The net profit for Q1 2025 was a loss of CNY 887,474.06, compared to a profit of CNY 11,492,136.80 in Q1 2024, marking a significant decline[39] - Operating profit for Q1 2025 was a loss of CNY 1,037,240.63, compared to a profit of CNY 4,523,864.65 in Q1 2024[39] - Total revenue for Q1 2025 was CNY 24,298,661.55, a decrease from CNY 34,275,554.02 in Q1 2024, representing a decline of approximately 29%[38] - Total operating costs for Q1 2025 were CNY 26,827,981.58, down from CNY 33,383,479.58 in Q1 2024, indicating a reduction of about 20%[38] - The basic earnings per share for Q1 2025 was -CNY 0.01, down from CNY 0.16 in Q1 2024[40] - Other income for Q1 2025 was CNY 2,139,574.75, compared to CNY 4,128,836.83 in Q1 2024, indicating a decrease of approximately 48%[38] Cash Flow - The net cash flow from operating activities was negative CNY 119,912,281.22, a decrease of 728.33% from negative CNY 14,476,421.59 in the previous year[11] - Cash flow from operating activities in Q1 2025 was a net outflow of CNY 119,912,281.22, compared to a net outflow of CNY 14,476,421.59 in Q1 2024[44] - The total cash inflow from investment activities in Q1 2025 was CNY 101,708.31, while cash outflow was CNY 11,305,006.37, resulting in a net cash outflow of CNY 11,203,298.06[45] - The company experienced a significant cash flow deficit in operating and investing activities, impacting overall financial health[47] - The net increase in cash and cash equivalents was -$90.48 million, contrasting with a positive increase of $106.88 million in the prior period[47] - The ending balance of cash and cash equivalents stood at $109.81 million, down from $187.74 million, reflecting liquidity challenges[47] Assets and Liabilities - Total assets decreased by 5.06% to CNY 861,434,797.75 compared to the end of the previous year[11] - Total current assets decreased to CNY 689,000,025.75 as of March 31, 2025, from CNY 733,256,649.92 on December 31, 2024, representing a decline of approximately 6.0%[31] - Total liabilities decreased to CNY 374,837,661.66 as of March 31, 2025, from CNY 419,856,665.06 on December 31, 2024, representing a decline of approximately 10.7%[33] - Total equity remained relatively stable at CNY 486,597,136.09 as of March 31, 2025, compared to CNY 487,484,610.15 on December 31, 2024, showing a minor decrease of about 0.2%[33] - The company reported a total of CNY 62,129,162.43 in accounts payable as of March 31, 2025, down from CNY 109,401,447.69 on December 31, 2024, indicating a decrease of about 43.1%[32] Inventory and Accounts Receivable - Inventory increased by 46.46% to CNY 271,946,776.95 due to the 2024 seed production storage[12] - Accounts receivable increased to CNY 201,150,013.71 as of March 31, 2025, compared to CNY 190,675,724.90 on December 31, 2024, reflecting an increase of about 5.0%[31] - Inventory rose significantly to CNY 271,946,776.95 as of March 31, 2025, up from CNY 185,685,549.05 on December 31, 2024, indicating a growth of approximately 46.4%[31] Shareholder Information - The total number of ordinary shareholders was 3,504 as of the report date[18] - The largest shareholder, Fang Yanli, holds 36,595,000 shares, representing 51.56% of the total shares[19] - The total shares held by the top ten shareholders amount to 47,395,783, which is 66.78% of the total shares[20] Legal and Commitments - The company has ongoing litigation with a total amount of 2,912,200, accounting for 0.60% of the net assets[24] - All disclosed commitments are being fulfilled normally as of the report date[26] Related Party Transactions - The company’s related party transactions with Ningxia Kangnong are expected to include approximately 15.5 million for 2024 seed procurement[25]

Capital Structure and Shareholder Information - The total share capital of Hubei Kangnong Seed Co., Ltd. is 70,972,200 shares after a recent increase from 54,594,000 shares due to a stock dividend distribution[20]. - The company reported a significant increase in registered capital, which rose to 70,972,200 yuan following the issuance of 15,134,000 shares to unspecified qualified investors[19]. - The total number of ordinary shares increased from 39,460,000 to 70,972,200 after a public offering and subsequent stock dividend[136]. - The largest shareholder, Fang Yanli, holds 36,595,000 shares, representing 51.56% of the total shares[137]. - The controlling shareholder, Fang Yanli, holds 51.56% of the company's shares, ensuring significant control over company decisions[142]. - The total number of ordinary shareholders is 3,409[135]. - The company’s core employees hold 598,449 shares, which is 0.84% of the total shares[135]. - The total number of shares to be increased through the profit distribution plan is 16,378,200 shares, which aligns with the company's profit distribution policy[155]. Financial Performance - Net profit attributable to shareholders reached ¥82,599,891.43, marking a 55.21% growth from the previous year[27]. - Operating income grew to ¥336,657,483.70, representing a 16.80% increase compared to 2023[27]. - The company's gross profit margin improved to 35.79%, up from 30.73% in the previous year[27]. - Total assets increased to ¥907,341,275.21, a growth of 68.38% compared to the end of 2023[26]. - Total liabilities rose to ¥419,856,665.06, reflecting a 57.82% increase year-over-year[26]. - The company's cash and cash equivalents increased by 189.24% to CNY 252.46 million, primarily due to funds raised from the IPO and improved sales collection[51]. - The company achieved operating revenue of CNY 336.66 million, a year-on-year increase of 16.80%[42]. - The company reported a net profit of CNY 83.24 million in 2024, representing a 55.09% increase compared to CNY 53.67 million in 2023[56]. Research and Development - The company has established a biological breeding research institute, indicating a focus on innovation and research in agricultural biotechnology[14]. - R&D expenditure for the period was CNY 14,376,588.99, accounting for 4.27% of operating income, an increase from 3.73% in the previous year[86]. - The total number of R&D personnel decreased from 21 to 20, while the proportion of R&D personnel to total employees increased from 13.79% to 19.09%[83]. - The company holds 38 patents, down from 63 in the previous period, with 6 of them being invention patents[84]. - The company is conducting a project on tropical corn, which has been completed and is expected to enhance market coverage in tropical regions[85]. - The company plans to focus on developing high-yield and resilient corn varieties to enhance food security in China[47]. Market Expansion and Sales Strategy - The company has plans for market expansion and product development, although specific future projections were not detailed in the report[11]. - The company plans to accelerate market expansion in the Huang-Huai-Hai and East North China regions by increasing seed production area and promoting quality varieties[105]. - The company aims to explore international markets and seek overseas partners to promote its products and services globally[105]. - The company is focusing on technological innovation in breeding research, establishing major research platforms, and introducing high-level talent[108]. - The marketing strategy includes consolidating its position in the Southwest, expanding into new markets, and enhancing online marketing efforts to increase product visibility and sales[108]. Governance and Risk Management - The company has a robust financial oversight structure, with a dedicated board of supervisors and management team ensuring accountability[10]. - The company emphasizes risk management, with a section in the report dedicated to analyzing major risk factors that could impact operations[12]. - The company has established a governance structure to mitigate risks associated with the actual controller's influence on major decisions, ensuring the protection of minority shareholders' interests[113]. - The company has not reported any significant changes in risk factors during the reporting period, indicating stable operational conditions[114]. - The company has implemented a scientific dealer management system to mitigate risks associated with a growing number of distributors[110]. Employee and Management Structure - The total number of employees increased from 110 to 145, reflecting a 31.8% growth in workforce[170]. - The total number of management personnel increased from 17 to 24, a 41.2% increase[170]. - The total number of production personnel increased from 35 to 58, a 65.7% increase[170]. - The company has established new governance systems, including the "Investment Management System" and "Public Opinion Management System," to enhance operational standards[182]. - The company has appointed new independent directors to enhance governance structure, with one leaving for personal development[165]. Commitments and Compliance - The company has committed to fulfilling social security contributions as per legal requirements[130]. - The company has not faced any violations of commitments during the reporting period[130]. - The company has ongoing commitments to adhere to profit distribution policies as per relevant laws and regulations, with compliance in progress[128]. - The company has not reported any new significant related party transactions or commitments as of the latest disclosure[127]. - The company has confirmed that there are no financial transactions with related financial companies, ensuring independence in its operations[127].

湖北康农种业股份有限公司监事会主席任命公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、任免基本情况 （一）任免的基本情况 证券代码：837403 证券简称：康农种业 公告编号：2025-024 公司新任董事、监事、高级管理人员候选人的任职资格符合法律法规、部门规章、 业务规则和公司章程等规定。本次任命未导致董事会中兼任高级管理人员的董事和由职 工代表担任的董事人数超过公司董事总数的二分之一。 本次任命不存在公司董事、高级管理人员兼任本公司监事的情形；不存在公司监事 为公司董事、高级管理人员的配偶、父母和子女情形。 （一）对公司生产、经营的影响： 根据《公司法》及《公司章程》的有关规定，公司第三届监事会第二十二次会议于 2025 年 4 月 10 日审议并通过《关于选举监事会主席的议案》。 任命郭春燕女士为公司监事会主席，任职期限至第三届监事会任期届满之日止，自 2025 年 4 月 10 日起生效。上述任命人员持有公司股份 65,000 股，占公司股本的 0.09%， 不是失信联合惩戒对象。 （ ...

证券代码：837403 证券简称：康农种业 公告编号：2025-021 湖北康农种业股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 10 日 2.会议召开地点：湖北长阳经济开发区长阳大道 553 号 3.会议召开方式：现场和网络投票相结合的方式 4.会议召集人：董事会 5.会议主持人：董事长方燕丽女士 6.召开情况合法、合规、合章程性说明： 本次股东大会的召集、召开、议案审议程序符合《中华人民共和国公司法》 《湖北康农种业股份有限公司章程》的相关规定，所作决议合法有效。 （二）会议出席情况 4.公司高级管理人员列席会议。 二、议案审议情况 审议通过《关于提名张琴为公司第三届监事会非职工代表监事的议案》 1.议案内容： 出席和授权出席本次股东大会的股东共 8 人，持有表决权的股份总数 40,599,500 股，占公司有表决权股份总数的 57.20%。 其中通过网络投票参 ...

证券代码：837403 证券简称：康农种业 公告编号：2025-023 湖北康农种业股份有限公司 第三届监事会第二十二次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 10 日 2.会议召开地点：公司会议室 5.会议主持人：本次会议由过半数的监事共同推举郭春燕女士主持 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序均符合《中华人民共和国公司法》和 《湖北康农种业股份有限公司章程》的规定，所作决议合法有效。 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于选举监事会主席的议案》 1.议案内容： 前任监事会主席因个人原因已申请辞职，公司监事会同意选举郭春燕女士为 公司第三届监事会主席，任期自本次监事会审议通过之日起至第三届监事会届满 3.会议召开方式：采用现场和通讯相结合的方式 4.发出监事会会议通知的时间和方式：2025 年 4 月 7 ...

北京金诚同达（上海）律师事务所 关于 湖北康农种业股份有限公司 2025 年第一次临时股东大会的 法律意见书 诚同达律师事务所 ENG TONGDA & NEAL LAW FIRM 上海市浦东新区世纪大道 88 号金茂大厦 18 层 电话: 021-3886 2288 传真: 021-3886 2288 转 1018 金诚同达律师事务所 法律意见书 北京金诚同达（上海）律师事务所 关于湖北康农种业股份有限公司 2025 年第一次临时股东大会的 法律意见书 金沪法意[2025] 第 97 号 1 s y 金诚同达律师事务所 法律意见书 致:湖北康农种业股份有限公司 北京金诚同达(上海)律师事务所(以下简称"本所")接受湖北康农种业 股份有限公司(以下简称"公司")的聘请,指派本所律师出席公司 2025 年第一 次临时股东大会(以下简称"本次股东大会")并对会议的相关事项出具法律意 见书。 本所律师根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人 民共和国证券法》《上市公司股东会规则》(以下简称"《股东会规则》")《律师事 务所从事证券法律业务管理办法》《律师事务所证券法律业务执业规则(试行)》 ...

证券代码：837403 证券简称：康农种业 公告编号：2025-017 湖北康农种业股份有限公司监事任命公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、任免基本情况 （一）任免的基本情况 2025 年 3 月 25 日，公司召开第三届监事会第二十一次会议，审议通过《关于提名 张琴为公司第三届监事会非职工代表监事的议案》，表决结果为同意 3 票，反对 0 票， 弃权 0 票，该议案尚需提交公司 2025 年第一次临时股东大会审议。 提名张琴女士为公司监事，任职期限至第三届监事会届满之日止，本次任免尚需提 交股东大会审议，自 2025 年第一次临时股东大会决议通过之日起生效。上述提名人员 持有公司股份 0 股，占公司股本的 0%，不是失信联合惩戒对象。 （二）任命原因 公司原非职工代表监事金长春先生因个人原因，申请辞去公司第三届监事会监事、 监事会主席职务，为保障公司监事会的正常运作，公司监事会提名张琴女士为公司第三 届监事会非职工代表监事候选人。 （三）新任董监高人员履历 张琴女士，1986 年 ...

证券代码：837403 证券简称：康农种业 公告编号：2025-014 湖北康农种业股份有限公司 关于出售参股公司股权的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、交易概况 （一）基本情况 基于经营发展需要，湖北康农种业股份有限公司（以下简称"康农种业"或 "公司"）拟与青岛青创汇金投资合伙企业（有限合伙）签署股权转让协议，拟 向青岛青创汇金投资合伙企业（有限合伙）转让公司持有的未米生物科技（青岛） 有限公司（以下简称"未米生物"）2.43%的股权。本次股权转让完成后，公司将 不再持有未米生物的股权。 （二）是否构成重大资产重组 本次交易不构成重大资产重组。 《上市公司重大资产重组管理办法》（以下简称"《重组管理办法》"）第二 条："本办法适用于上市公司及其控股或者控制的公司在日常经营活动之外购买、 出售资产或者通过其他方式进行资产交易达到规定的标准，导致上市公司的主营 业务、资产、收入发生重大变化的资产交易行为（以下简称重大资产重组）。" 第十二条规定："上市公司及其控股或者控制的公司购 ...

证券代码：837403 证券简称：康农种业 公告编号：2025-012 湖北康农种业股份有限公司 关于预计 2025 年日常性关联交易的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 日常性关联交易预计情况 （一） 预计情况 单位：元 | 关联交易类别 | 主要交易内容 | 预计 2025 | 年发 | 2024 年与关联 | 预计金额与上年实际发生金 | | --- | --- | --- | --- | --- | --- | | | | 生金额 | | 方实际发生金额 | 额差异较大的原因 | | 购买原材料、燃料 | 杂交玉米种子 制种采购 | 28,500,000.00 | | 19,631,187.75 | 公司根据自身经营战略和供 应商选择情况调整供应商的 | | 和动力、接受劳务 | | | | | 制种面积所致。 | | 销售产品、商品、 | | | | | | | 提供劳务 | | | | | | | 委托关联方销售 | | | | | | | 产品、商品 | | | | ...

证券代码：837403 证券简称：康农种业 公告编号：2025-018 湖北康农种业股份有限公司 关于召开 2025 年第一次临时股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开基本情况 （一）股东大会届次 （五）会议召开日期和时间 本次会议为 2025 年第一次临时股东大会。 （二）召集人 本次股东大会的召集人为董事会。 2025 年 3 月 25 日，湖北康农种业股份有限公司召开了第三届董事会第二十 三次会议，审议通过《关于提请召开 2025 年第一次临时股东大会的议案》，公司 董事会根据本次会议决议召集股东大会。 （三）会议召开的合法性、合规性 本次会议的召集、召开程序符合《中华人民共和国公司法》等相关法律法规 及《湖北康农种业股份有限公司章程》的有关规定。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司同一股东只能选择现场投票、网络投票中的一种方式，如果同一表决 权出现重复投票表决的，以第一次投票表决结果为准。 1、现场会议 ...